Schedule 13G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No.     )*

 

 

Harvard Bioscience, Inc.

(Name of Issuer)

Common Stock, $0.01 Par Value

(Title of Class of Securities)

416906105

(CUSIP Number)

December 31, 2013

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

x Rule 13d-1(b)

¨ Rule 13d-1(c)

¨ Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


SCHEDULE 13G

 

CUSIP No. 416906105       Page 2 of 6

 

 

  1   

Names of reporting persons

 

Granahan Investment Management, Inc.

  2  

Check the appropriate box if a member of a group*

(a)  ¨        (b)  ¨

 

  3  

SEC use only

 

  4  

Citizenship or place of organization

 

    Massachusetts

Number of

shares

beneficially

owned by

each

reporting

person

with:

     

Sole voting power

 

    12,361

   6   

Shared voting power

 

    0

   7   

Sole dispositive power

 

    1,723,960

   8   

Shared dispositive power

 

    0

  9  

Aggregate amount beneficially owned by each reporting person

 

    1,723,960

10  

Check if the aggregate amount in Row (9) excludes certain shares    ¨

 

11  

Percent of class represented by amount in Row 9

 

    5.6% (1)

12  

Type of reporting person

 

    IA

 

(1) Reflects 31,010,105 shares of common stock outstanding as of November 1, 2013, as reported by Harvard Bioscience, Inc. in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 8, 2013.


SCHEDULE 13G

 

CUSIP No. 416906105       Page 3 of 6

 

 

Item 1(a). Name of Issuer:

Harvard Bioscience, Inc.

 

Item 1(b). Address of Issuer’s Principal Executive Offices:

84 October Hill Road

Holliston, MA

 

Item 2(a). Name of Person Filing:

Granahan Investment Management, Inc.

 

Item 2(b). Address of Principal Business Office or, if None, Residence:

275 Wyman Street, Suite 270

Waltham, MA 02451

 

Item 2(c). Citizenship:

Massachusetts

 

Item 2(d). Title of Class of Securities:

Common Stock

 

Item 2(e). CUSIP No.:

416906105

 

Item 3. If This Statement is Filed Pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

 

(a)    ¨    Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);
(b)    ¨    Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)    ¨    Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)    ¨    Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)    x    An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)    ¨    An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);


SCHEDULE 13G

 

CUSIP No. 416906105       Page 4 of 6

 

 

(g)    ¨    A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)    ¨    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)    ¨    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)    ¨    A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
(k)    ¨    Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

 

Item 4. Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

  (a) Amount beneficially owned: 1,723,960

 

  (b) Percent of class: 5.6%

 

  (c) Number of shares as to which the person has:

 

  (i) sole power to vote or to direct the vote: 12,361

 

  (ii) shared power to vote or to direct the vote: 0

 

  (iii) sole power to dispose or to direct the disposition of: 1,723,960

 

  (iv) shared power to dispose or to direct the disposition of: 0

 

Item 5. Ownership of 5 Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following  ¨.


SCHEDULE 13G

 

CUSIP No. 416906105       Page 5 of 6

 

 

Item 6. Ownership of More than 5 Percent on Behalf of Another Person

Not Applicable

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

Not Applicable

 

Item 8. Identification and Classification of Members of the Group

Not Applicable

 

Item 9. Notice of Dissolution of Group

Not Applicable

 

Item 10. Certifications

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.


SCHEDULE 13G

 

CUSIP No. 416906105       Page 6 of 6

 

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

  GRANAHAN INVESTMENT MANAGEMENT, INC.
Date: February 14, 2014     By:  

/s/ Jane M. White

     

Jane M. White, President and CEO

      Name/Title